Cancer Research Annual Meeting 2010  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
[Cancer Research 65, 11785, December 15, 2005]
© 2005 American Association for Cancer Research

Targeting LPAAT-ß in Gynecologic Cancer

In the article on targeting LPAAT-ß in gynecologic cancer in the October 15, 2005 issue of Cancer Research (1), it should be noted that Dr. Gregory M. Springett's research was performed at the Memorial Sloan-Kettering Cancer Center, Developmental Chemotherapy Laboratory, Department of Medicine; he is currently at the H. Lee Moffitt Cancer Center, Drug Discovery Program and Department of Interdisciplinary Oncology. Also, the following should have appeared in the Acknowledgment: We thank the Memorial Sloan-Kettering Cancer Center Molecular Cytology Core for assistance with the confocal microscopy studies, Cyrus Hedvat for constructing the tissue microarrays, Mario Leitao for assistance in obtaining clinical follow-up information, and Jeni Moses for assistance in compound screening.

References

  1. Springett GM, Bonham L, Hummer A, Linkov I, Misra D, Ma C, Pezzoni G, Di Giovine S, Singer J, Kawasaki H, Spriggs D, Soslow R, Dupont J. Lysophosphatidic acid acyltransferase-ß is a prognostic marker and therapeutic target in gynecologic malignancies. Cancer Res 2005;65:9415–25.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online